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Department of Physics & Astronomy, Rice University, Houston, TexasABSTRACT A leading hypothesis for the decimation of insulin-producing b-cells in type 2 diabetes attributes the cause to islet
amyloid polypeptide (IAPP) for its deleterious effects on the cell membranes. This idea has produced extensive investigations on
human IAPP (hIAPP) and its interactions with lipid bilayers. However, it is still difficult to correlate the peptide-lipid interactions
with its effects on islet cells in culture. The hIAPP fibrils have been shown to interact with lipids and damage lipid bilayers, but
appear to have no effect on islet cells in culture. Thus, a modified amyloid hypothesis assumes that the toxicity is caused by
hIAPP oligomers, which are not preamyloid fibrils or protofibrils. However, so far such oligomers have not been isolated or iden-
tified. The hIAPP monomers also bind to lipid bilayers, but the mode of interaction is not clear. Here, we performed two types of
experiments that, to our knowledge, have not been done before. We used x-ray diffraction, in conjunction with circular dichroism
measurement, to reveal the location of the peptide bound to a lipid bilayer. We also investigated the effects of hIAPP on giant
unilamellar vesicles at various peptide concentrations. We obtained the following qualitative results. Monomeric hIAPP binds
within the headgroup region and expands the membrane area of a lipid bilayer. At low concentrations, such binding causes
no leakage or damage to the lipid bilayer. At high concentrations, the bound peptides transform to b-aggregates. The aggregates
exit the headgroup region and bind to the surface of lipid bilayers. The damage by the surface bound b-aggregates depends on
the aggregation size. The initial aggregation extracts lipid molecules, which probably causes ion permeation, but no molecular
leakage. However, the initial b-aggregates serve as the seed for larger fibrils, in the manner of the Jarrett-Lansbury seeded-poly-
merization model, that eventually disintegrate lipid bilayers by electrostatic and hydrophobic interactions.INTRODUCTIONDiabetes affects nearly 8.3% of the American population
and is the seventh leading cause of death in the United
States. In adults, type 2 diabetes accounts for ~90–95% of
all diagnosed cases of diabetes (1). One possible cause of im-
paired insulin secretion in type 2 diabetes is attrition of
insulin-producing b-cells (2). Prevailing hypotheses that
explain the underlying cell attrition are the deleterious
effects on the cell membranes by human islet amyloid poly-
peptide (hIAPP), a 37-residue peptide that is synthesized in
pancreatic islet b-cells and cosecreted with insulin (3–7). A
large body of research has described the phenomena of
hIAPP interactions with lipid bilayers (see references
below). However, it has been difficult to correlate the effects
on lipid bilayers with the effects of hIAPP added to islet
cells in culture, which indeed induce cell death (6,8). In
this report, we studied the responses of giant unilamellar
vesicles (GUVs) exposed to hIAPP in various conditions.
To understand the physical process of hIAPP-GUV inter-
actions, we also performed x-ray diffraction (XRD) in
conjunction with circular dichroism (CD) measurements.
The combined results provide what to our knowledge is
new structural information about the hIAPP-membrane
interactions, and reveal a low threshold peptide concentra-Submitted October 17, 2011, and accepted for publication January 23,
2012.
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molecules at concentrations above the threshold convert to
b-sheet aggregates via membrane binding, which subse-
quently damage the lipid bilayer. We use these results to
speculate how islet amyloid polypeptide (IAPP) monomers
may interact with cell membranes.
A great deal of IAPP studies made use of the contrast
between hIAPP, which is amyloidogenic, and rodent IAPP
(rIAPP), which is not (9,10); both are 37-residue peptides
differing only in IAPP22-29 (10). Significantly, rodents do
not develop diabetes-like symptoms even when rIAPP is
overexpressed (11). Thus, the occurrence of diabetes in
hIAPP-transgenic rodents has been regarded as the strongest
evidence associating hIAPP with diabetes (12). However,
the initial assumption that the formation of extracellular
IAPP amyloid causes b-cell apoptosis has been disproved
by the absence of correlation between cytotoxicity and
extracellular amyloids (6,13). When amyloid fibrils were
added to islet cells in culture, apoptosis was not induced.
In contrast, if a freshly prepared aqueous solution of hIAPP
was added to islet cells in culture, cell death was reproduc-
ibly induced and electron microscopy (EM) revealed the
presence of small aggregates on cell membranes that were
interpreted as hIAPP oligomers disrupting the cell
membrane and penetrating the cell (3,8). Furthermore, the
drug rifampicin inhibited hIAPP amyloid formation but
failed to inhibit hIAPP cytotoxicity (13). Thus, in a current
amyloid hypothesis, the toxicity is caused by hIAPP oligo-
mers that are not preamyloid fibrils or protofibrils, but are andoi: 10.1016/j.bpj.2012.01.039
1060 Lee et al.off-amyloid fibril pathway form of oligomer (6). However,
so far the structures of these presumed toxic oligomers are
unknown (such as their CD), nor have such oligomers
been isolated (6). The possibility of hIAPP forming low-
molecular-weight oligomers was recently examined by
Vaiana et al. (14) using ultracentrifugation and by Soong
et al. (7) using diffusion NMR spectroscopy and both
obtained negative results.
The peptide hIAPP dissolves in aqueous solutions,
initially in random coil configurations as indicated by CD,
however the CD spectrum will gradually change to that of
b-sheet indicating b-amyloid formation (4,8). EM showed
the peptide turned into aggregates or fibrils (8,15,16). The
x-ray fiber diffraction (16) showed a meridional reflection
at 4.7 A˚ and an equatorial reflection at 9.5 A˚, corresponding
to the typical cross-b structure seen in the fibrils formed by
other amyloid diseases (17,18). The speed of change from
random coils to b-sheets in solution depended on the peptide
concentration, temperature, and other solution conditions,
such as pH, ions, and buffers (19). In general the higher
the concentration, the faster was the change rate. It seemed
possible that the peptide would remain a random coil at very
low concentrations, for example at the physiological circu-
lating concentrations of hIAPP (estimated to be 5–20 pM)
(6,20). The transition from random coil to b-sheet in solu-
tion appeared not to involve a-helical configuration. This
is in contrast to the conformation changes mediated by
membrane binding (5, 21–23). Human IAPP spontaneously
binds to lipid bilayers; particularly if the bilayers include
anionic lipids (IAPP has three cationic amino acids). If
IAPP was initially in random coils, the binding changed
its CD to a-helical form initially but the spectrum invariably
transformed to that of b-sheets in time (21,23). Again, the
membrane bound aggregates and fibrils have been seen by
EM (22) and by light microscope (24).
As summarized and reviewed recently by Gorbenko and
Kinnunen (25) and by Jayasinghe and Langen (5),
membranes have been implicated as the catalyst that facili-
tates fibril formation (21,22) and as the targets of IAPP
toxicity (3,4). A theory for membranes as amyloid-catalyses
has been advanced by Apostolidou et al. (26) who obtained
the electron paramagnetic resonance-resolved a-helical core
(residues 9–22) of hIAPP bound to lipid vesicles; they sug-
gested that the lining up of the helical parts on the surface of
membranes facilitates the aggregation and b-sheet forma-
tion of the amyloidogenic regions of hIAPP. The toxicity
effect has been attributed to IAPP-induced membrane per-
meabilization, variably described as ion channels/pores
(3,4,15,27–29) or membrane damage by the extraction of
lipids from the bilayer (24,30–32). More recently Engel
et al. (33) investigated the correlations between the growth
of peptide fibril and their effects on lipid vesicles. They
concluded that preformed or mature hIAPP fibrils did not
interact or damage lipid bilayers, but during the growth of
fibrils from membrane-bound monomers, the peptide-lipidBiophysical Journal 102(5) 1059–1068interactions extracted lipids from the bilayers that caused
membrane damages. On the other hand, Knight et al. (23)
proposed that it is the aggregation of the IAPP a-helices
on the membrane that induces toxicity. Somewhat similar
to Soong et al. (7) who suggested that the toxicity was
due to well-defined ion channels formed by aggregation of
monomeric IAPPs bound to the membrane.
In this work we hope to gain a better understanding of the
physical process in which hIAPP induces membrane
damage. We will gain this understanding by new experi-
ments and also by comparing the effects of hIAPP with
the known behaviors of other membrane-active peptides.
In particular, the membrane-mediated amyloid formation
of penetratin is a useful reference for the more complex
reactions by hIAPP. Penetratin dissolves in solution as
a random coil and has never been found in the b-amyloid
form in solution. However, it binds to the lipid bilayer inter-
face in the a-helical form as long as the peptide/lipid ratio
(P/L) is below a lipid-dependent threshold value. As soon
as P/L exceeds the threshold value, penetration progres-
sively transforms to b-aggregates and exits from the lipid
bilayer interface (34). The process of forming the b-aggre-
gates extracts lipid molecules from the lipid bilayer. We
will see that hIAPP exhibits a similar behavior.EXPERIMENT
Materials
Human IAPP, KCNTATCATQRLANFLVHSSNNFGAILS
STNVGSNTY-NH2 (disulfide bridge: 2–7), was synthe-
sized to HPLC purity > 95% by AnaSpec (Fremont, CA).
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-di-
(9Z-octadecenoyl)-sn-glycero-3-phospho-(10-rac-glycerol)
(DOPG), and 1,2-dioleoyl-sn-glycero-3-phosphoethanol-
amine-N-(Lissamine Rhodamine B Sulfonyl) (Rh-DOPE)
were purchased from Avanti Polar Lipids (Alabaster, AL).
All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO) and were used without further purification.
Sample preparation is separately specified for each exper-
iment below. All experiments were performed at room
temperature ~25C.Preparation of monomeric hIAPP
We followed an established protocol for the preparation of
monomeric hIAPP (4,7). The hIAPP was first dissolved in
hexafluoroisopropanol at 0.5 mg/mL and sonicated for
5 min. The solution was then lyophilized. A stock solution
of 100 mM hIAPP was prepared in 200 mM glucose solu-
tion. The peptide configuration in the solution was continu-
ously monitored by CD. The result showed that hIAPP
remained in random coil configurations for at least 1 week
in pure glucose solution. On the other hand, if hIAPP was
dissolved in 199 mM glucose and 1 mM Tris buffer (at
How hIAPP Damages Lipid Bilayers 1061pH 7.0), b-aggregate started to form in ~4 h. For each run of
the experiment, the stock solution was diluted with 199 mM
glucose and 1mM Tris (at pH 7.0) to a desired hIAPP
concentration. CD spectrum was measured to confirm that
the peptide was in random coil form. The solution was
used immediately after dilution and the experimental time
for each run was ~20 min.Preparation of hIAPP fibrils
A stock solution of 200 mM hIAPP was made in 190 mM
glucose and 10 mM Tris (at pH 7.0) solution. For the
experiment, the stock solution was diluted with 199 mM
glucose and 1 mM Tris (at pH 7.0) to a desired hIAPP
concentration.
Fibrillization of peptide samples was monitored by a thio-
flavin T (ThT) dye binding assay (4,33). Diluted samples
were mixed with ThT (2 mM) and its fluorescence was
measured by a spectrophotometer (Ocean Optics, Dunedin,
FL). We found that the ThT fluorescence saturated after ~6 h
(see the Supporting Material). CD spectrum was measured
to check that the hIAPP was indeed in the b form. For exper-
iments with mature hIAPP fibrils, the stock solution was
kept at 4C for 2 weeks.Aspirated GUV experiments
The experiments were performed as described in Sun et al.
(35). Briefly, GUVs of pure DOPC or 7:3 DOPC/DOPG,
plus 0.5 mol % Rh-DOPE, were produced in 200 mM
sucrose solution by electroformation (36), and were trans-
ferred to a control chamber containing 199 mM glucose
and 1 mM Tris (pH 7.0). A GUV was aspirated by a micro-
pipette with a small constant sucking pressure (~100 Pa
producing a membrane tension ~0.4 mN/m) in the control
chamber and then transferred, via a transfer pipette (35),
to an observation chamber containing 199 mM glucose,
1mM Tris, and hIAPP at a specified concentration. The
osmolality of every solution used in the GUV experiment
was measured by a dew-point Wescor osmometer (model
5520) (Logan, UT). Solutions of the same osmolality were
used inside and outside of the GUV in each experiment.
The experiment was recorded by fluorescence imaging
using a Nikon CoolSNAP HQ2 camera (Tokyo, Japan).
The phase contrast between the sucrose solution inside the
GUV and the glucose solution outside was inspected at
randomly chosen times to determine if any change occurred.
The analysis of the GUV response is based on the change
of the protrusion length Lp of the GUV in the micropipette
(37): Under the condition of no volume change, the change
of membrane area is DA ¼ 2pRpð1 Rp=RvÞDLp, where Rp
and Rv are radii of the micropipette and the GUV. All the
values of Rp, Rv, and Lp were carefully measured and
analyzed by using the Nikon NIS-Elements BR 2.30 soft-
ware. To normalize the area changes in different GUVs,DLp was converted to the fractional change of the vesicle
area DA/A.HIAPP b-fibrils mixed with GUVs
10 mL of the GUV suspension was transferred to an obser-
vation chamber containing 199 mM glucose, 1 mM Tris at
pH 7.0, and 2.5 mM hIAPP in b-fibril form. The GUVs
settled to the bottom due to the density differential and
were observed with a Nikon confocal microscope (Tokyo,
Japan).GUV leakage experiment
For the leakage experiment, the solution in the GUV
production chamber also contained 10 mM calcein. Two
observation chambers containing the same solution
(199 mM glucose and 1mM Tris at pH 7.0) were set side
by side. 10 mL of the GUV suspension was injected into
the first observation chamber and were well mixed with
the solution in the chamber by stirring with a micropipette.
About 10 GUVs were transferred from the first to the second
chamber via a transfer pipette. The purpose of this transfer-
ring procedure was to dilute the untrapped calcein. The
GUVs settled at the bottom due to the density differential
and were observed under an Olympus microscope (model
IX81) (Tokyo, Japan) and recorded with a Hamamatsu
Photonics digital charge-coupled device camera (model
C10600-10B) (Hamamatsu City, Japan). 0.5 mL of the
monomeric hIAPP stock solution was injected into the
observation chamber (to a final concentration 0.1 mM) and
GUVs were observed for 5 min. Another 0.5 mL was then
injected and observed for the next 5 min. This process
was repeated in the sequence of increasing hIAPP concen-
trations, until all the GUVs under observation ruptured.
The highest final hIAPP concentration in the observation
chamber was 0.5 mM. The leakage of GUV content was
monitored by calcein fluorescence. During the experiment,
the lipid dye and content dye were inspected alternately
by switching between two dichroic/filter sets.Preparation of multilayer samples for CD and XRD
The procedure for preparing peptide/lipid mixtures into
aligned multiple layers has been fully described in Ludtke
et al. (38). IAPP was first dissolved in tetrafluoroethylene.
Appropriate amounts of IAPP and DOPC for a chosen
peptide/lipid molar ratio, P/L, were mixed in 1:1 (v/v) chlo-
roform and tetrafluoroethylene. The mixture was uniformly
spread on a thoroughly cleaned quartz substrate (0.05 mg
peptide on a 1 cm2 quartz plate for P/L > 1/30; 0.3 mg of
lipid on a 1 cm2 plate for P/L % 1/30). After the solvent
evaporated in vacuum, the sample was hydrated with 50%
relative humidity (RH) water vapor at room temperature
overnight. The results were well-aligned parallel bilayers,Biophysical Journal 102(5) 1059–1068
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were housed in a temperature humidity chamber in which
the hydration level of the sample was controlled by the
RH of water vapor (39). All measurements were performed
at 25C and 60–98% RH.CD experiment
CD spectra were measured in a Jasco (Tokyo, Japan) J-810
spectropolarimeter. The substrates of multilayer samples
were oriented normal to the incident light, as for the
measurement of oriented circular dichroism (40). The back-
ground spectrum for each sample was the spectrum for the
same amount of lipid on the same substrate. After the back-
ground correction, the spectra of different P/Ls were
normalized to the same amount of hIAPP.FIGURE 1 Time sequence of a GUV (7:3 DOPC/DOPG, plus 0.5 mol %
Rh-DOPE) containing 200 mM sucrose exposed to 0.25 mM monomeric
hIAPP in 199 mM glucose and 1 mM Tris buffer (pH 7.0). (A) t ¼ 0; (B)
the protrusion length first increased; (C) the protrusion length then
decreased; (D) the high-contrast fluorescence image of (C) shows aggre-
gates (indicated by arrows)—some appeared to be coming off the surface
of GUV (see Movie S1 in the Supporting Material). Scale bar ¼ 20 mm.XRD experiment
The x-ray samples were prepared and measured in a temper-
ature-humidity chamber at the same conditions as for the
CD experiment. u-2q diffraction was collected on a four-
circle Huber goniometer (Huber Diffraktionstechnik, Rimst-
ing, Germany), with a vertical line-focused Cu Ka source
(l ¼ 1.542 A˚) operating at 35 kV and 15–30 mA. The
incident beam was collimated by a horizontal soller slit
and two vertical slits on the front and the back sides of
the soller slit. The horizontal and vertical divergences of
the incident beam were 0.23 and 0.3, respectively. The
diffracted beam first passed through a vertical slit and then
was discriminated by a bent graphite monochromator before
entering a scintillation detector, which was biased to
discriminate against x rays other than 1.542 A˚, including
Compton scattering and fluorescence, and against x rays
from air scattering. This diffractometer was designed to
minimize the background signal, as a result allowing the
measurement of high diffraction orders.
Before the measurement, the aligned multilayer sample
was carefully positioned at the center of the x-ray beam
and was oriented so that u ¼ 0 and q ¼ 0 coincided.
We have established an elaborate routine for positioning
and orienting the sample as described in Wu et al. (41). A
two-dimensional u-q around the second or the third Bragg
order was used to check the alignment of the u angle and
the mosaic of the multilayers alignment. Typically the full
width at half-maximum of the peak on the u axis (of the
u-q scan) was 0.2–0.3 (example in (42)). Once the sample
was properly positioned and aligned on the diffractometer,
each u-2q scan was performed from u ¼ 0.5 to u ¼ 7.5
with a step size of Du ¼ 0.01. An attenuator was used to
prevent the first-order Bragg peak from saturating the
detector. The scan was repeated 2–3 times for each hydra-
tion level and then averaged for data analysis.
The procedure of data reduction was described in many of
our previous works (43,44). Briefly, the measured diffrac-Biophysical Journal 102(5) 1059–1068tion intensity was first corrected for the attenuator absorp-
tion and for the detector’s deadtime factor. After removing
the background, data were corrected for sample absorption
and diffraction volume. The integrated peak intensities
were then corrected for the polarization and the Lorentz
factors. The relative magnitude of the diffraction amplitude
was the square-root of the integrated intensity. The phases
were determined by the swelling method. With their phases
determined, the diffraction amplitudes were used to recon-
struct the electron density profile of the bilayer. Across
the bilayer profile, the phosphate peak-to-phosphate peak
distance (PtP) was measured for the bilayer thickness.
Measurements by the previously described procedure have
been done for various peptide-lipid mixtures for more than
a decade, e.g. (41,42,44). We found in each case the
measured PtP reproducible within 50.2 A˚.RESULTS
Aspirated GUV exposed to monomeric hIAPP
Besides the apparently different binding affinities to neutral
and anionic lipid bilayers, the reaction of GUVs of phospho-
choline and of phosphocholine/phosphoglycerol to hIAPP
binding is entirely similar. The reaction of an aspirated
GUV when exposed to monomeric hIAPP depended on
the peptide concentration. At low concentrations (e.g.,
0.05 mM), the binding of hIAPP simply lengthened the
GUV protrusion length (i.e., expanded the membrane
area). At high concentrations (e.g., 1 mM), the binding of
hIAPP caused the protrusion to increase to a maximum
and then decreased. As the protrusion length decreased,
small aggregates containing lipid dye appeared on the
surface of the GUV; some of these aggregates would
come off the GUV surface (Fig. 1, also Supporting Mate-
rial). Of importance, we found the phase contrast between
the GUV interior (sucrose) and the solution background
(glucose) did not change during the whole process, indi-
cating that no leakage of the GUV content occurred.
The protrusion length decrease could be due to either a
GUV volume increase at constant membrane area or a
membrane area decrease at constant volume (37,45,46).
One possibility for volume increase is due to the formation
FIGURE 2 (A) GUV (7:3 DOPC/DOPG, plus 0.5 mol % Rh-DOPE) con-
taining 200 mM sucrose exposed to three different concentrations of mono-
meric hIAPP in 199 mM glucose and 1 mM Tris buffer (pH 7.0). The
change of protrusion length was converted to 6A/A as a function of time
(only two curves are shown for each concentration): 1 mM (red), 0.5 mM
(blue), 0.05 mM (green) of monomeric hIAPP. (B) Same as (A) except
that the monomeric hIAPP was replaced by hIAPP b-fibrils at 0.25 mM.
In both A and B, different symbols represent different runs. With the excep-
tion of the case of 0.05 mM (green) in A, the GUV ruptured after the last
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magainin binding (46). The finite-sized pores would allow
the permeation of the smaller glucose into the vesicle
more than the permeation of the larger sucrose out of the
vesicle; and the resulted osmolality imbalance would induce
a net water influx to cause a volume increase at constant
membrane area—hence the protrusion length decrease
(45,47). This did not happen with hIAPP, because the phase
contrast of the GUV did not change (47). To further prove
that the hIAPP-induced protrusion decrease was not by
pore formation, we repeated the experiment both inside
and outside of the GUV in sucrose solutions. In this case,
the protrusion length would not decrease (because there
would be no net influx or efflux) if the effect of hIAPP
was inducing pores (as shown in (46)); but the protrusion
length did decrease (see the Supporting Material). This
proved that the observed decrease of protrusion length
was due to a membrane area decrease. This phenomenon
is similar to the binding of penetratin to GUV reported
earlier (34). In both cases, we observed small aggregates
of lipids coming off the surface of GUV while the protrusion
length was decreasing.
Fig. 2 A shows representative curves of DA/A, the frac-
tional change of vesicle area, as a function of time, for three
different concentrations of hIAPP. At 1 mM, the increase-
decrease of protrusion length occurred after ~5 s of the
GUVs exposure to hIAPP and then the GUV ruptured. At
0.5 mM of hIAPP, the increase-decrease occurred ~10 s after
the hIAPP exposure. At 0.05 mM hIAPP, the protrusion
length steadily increased for most of the time.data point.Leakage experiment with monomeric hIAPP
The purpose of the leakage experiment is to investigate if
there is hIAPP-induced leakage from the GUV before its
rupture. Free (not aspirated) GUVs containing solution
dye were first exposed to monomeric hIAPP at 0.1 mM for
5 min. No dye leakage was observed, but some small aggre-
gates came off the surface from a few GUVs (same as Fig. 1
D). When the peptide concentration was increased to 0.2
mM for the next 5 min and then to 0.3 mM for another
5 min, more aggregates were seen coming off the surface
of GUVs and a few GUVs ruptured. As the peptide concen-
tration was increased to 0.4 mM and then 0.5 mM, the rupture
became more frequent. Upon rupture, the dye content of
GUV leaked out instantly and the GUV disintegrated
(Fig. 3). We have never observed gradual leakage by hIAPP.
There was no leakage from the GUVs before rupture. The
reaction of GUVs to monomeric hIAPP was distinctly
different from the reaction of GUVs to antimicrobial
peptides, such as magainin (48,49) and melittin (47), which
are known to induce pores in the membranes. First, antimi-
crobial peptides at similar concentrations did not cause
GUV disintegration. Second, the leakage by antimicrobial
peptides was gradual and its rate changed with the peptideconcentration; the smaller the concentration the slower the
rate. For example, the complete leak-out time by magainin
was ~1 min at concentration ~1 mM, but lengthened to
~10 min as concentrations decreased to sub-mM (48).GUV interaction with hIAPP fibrils
When an aspirated GUV was exposed to hIAPP fibrils, the
fibrils were seen attached to the surface of GUV (it was
visible because the fibrils extracted lipid molecules
including dye from the bilayer). However, unlike mono-
meric hIAPP, fibrils did not cause an increase of the protru-
sion length; they only caused its decrease (Fig. 2 B) and
caused GUV rupture.
When a suspension of GUVs was injected into a suspen-
sion of hIAPP fibrils, the vesicles were disintegrated and the
lipids became part of the fibril network (Fig. 4).Combined results of CD and XRD
Note that the samples were prepared in a dry condition of
50% RH (the reason will become clear). We started CDBiophysical Journal 102(5) 1059–1068
FIGURE 3 Leakage experiment. GUVs (7:3 DOPC/DOPG, plus 0.5 mol
% Rh-DOPE) containing 10 mM calcein were exposed to increasing
concentrations of monomeric hIAPP at 0.1, 0.2,., 0.5 mM in 5 min inter-
vals. No gradual leakage was detected. The figure shows an example of rup-
ture occurring at concentration 0.3 mM: the lipid dye fluorescence images
A1 at 0 s; A2 at 660 s; A3 at 670 s; A4 at 680 s. The content dye fluores-
cence images (Bs) were recorded ~1 s after the corresponding lipid dye
images. (C) Shows the content dye fluorescence intensity in time. The
gradual decrease before rupture was due to photobleaching. The slight vari-
ations were due to varying fluorescence background. Scale bar ¼ 20 mm.
FIGURE 4 Confocal lipid-dye-fluorescence image of GUVs (7:3 DOPC/
DOPG, plus 0.5 mol % Rh-DOPE) exposed to hIAPP b-fibrils (2.5 mM) in
199 mM glucose and 1 mM Tris (at pH 7.0) solution. The GUVs disinte-
grated and lipids became part of the fibril network. Scale bar ¼100 mm.
1064 Lee et al.measurement from 60% RH and upward to 98% RH. The
sample was in each RH condition for at least 15 min. Hydra-
tion above 98% would make the sample too fluid to be held
vertically (necessary for both oriented CD and XRD).
DOPC/hIAPP mixtures from P/L ¼ 1/100 to 1/20 were
measured. The CD results were independent of the peptide
concentration. Fig. 5 shows the representative result. Below
~92% RH, hIAPPs bound in lipid bilayers were in the a-
helical form. According to the oriented CD spectra (40),
the helical axes were parallel to the plane of the bilayers.
As long as the sample was kept below 92% RH, the
a-helical CD was unchanged. However, when the hydration
changed toR96% RH, the CD spectrum began to change to
that of b-sheet (the CD measurement time was 3.6 min).
This change of spectrum was irreversible. If a hydrated
sample was dehydrated to below 96% RH, the spectrum re-
mained b-sheet like, independent of the hydration condition.
The CD samples were also measured by XRD in the
hydration sequence from 70% to 98% RH and then reversed
from 98% to 70% RH. The diffraction patterns showed well-Biophysical Journal 102(5) 1059–1068ordered bilayers in each sample of P/L ranging from 1/80 to
1/30. From the reconstructed electron density profiles for
the peptide-lipid bilayers, the changes of the phosphate-to-
phosphate distance across the bilayer (PtP) are shown in
Fig. 6. From the CD results, we know that the peptides
were in a-helical configuration during the hydration
sequence from 70% to 92% RH. However, once the sample
was hydrated to 98% RH, the peptides turned into b-sheet
configurations and remained in that configuration when
the sample was once again dehydrated. Fig. 6 A shows
that the thickness of pure DOPC was reversible by the
hydration-dehydration cycle, but not for the lipid bilayers
containing hIAPP. Once hIAPP turned into b-configura-
tions, the bilayer thickness at full hydration became the
same as pure lipid. In fact the electron density profiles ob-
tained from the multilayers containing hIAPP in the
b form are identical to that of pure lipid bilayers (Fig. 6
B). Clearly hIAPP molecules in the b form were not within
the lipid bilayers, otherwise the bilayer profiles would have
been altered from the free bilayer form. The values of PtP at
92% RH are plotted as a function of P/L in Fig. 6 C, showing
that when the bound hIAPP was in the a-helical form, the
bilayer thickness was reduced in proportion to P/L.
Membrane thinning in proportion to P/L implies that the
peptide in the a-helical form was bound within the head-
group region (34,38,41,50).
Many independent experiments (5,21,23) have shown
that monomeric hIAPPs bind to lipid vesicles initially in
the a-helical form, and then convert to b-configurations.
Our oriented circular dichroism and x-ray experiments
FIGURE 5 CD spectra of hIAPP in DOPC multiple bilayers at P/L ¼
1/50, prepared by first codissolving in organic solvent and, after the solvent
evaporated, equilibrating at 50% RH. The CD was measured in the
sequence of increasing hydrations. At and below 92% RH, hIAPP was in
a-helical form. At hydrations above 96% RH, hIAPP transformed to
b-configurations. The configuration change is irreversible. The result is
independent of the P/L ratio from 1/100 to 1/20.
FIGURE 6 CD samples (Fig. 5) were measured by XRD. (A) The phos-
phate-to-phosphate distance (PtP) of the bilayer electron density profiles
obtained from DOPC multilayers containing hIAPP (blue symbols)
compared with that of pure DOPC (red symbols) in the sequence of hydra-
tion-dehydration cycle indicated in the inset. (B) The electron density
profiles of DOPC multilayers containing hIAPP (blue line) compared
with that of pure DOPC (red line; mostly overlaying the blue line) at
98% RH. The profiles are the same within experimental resolution.
How hIAPP Damages Lipid Bilayers 1065with multilamellar samples are too slow to measure this
transitional a-helical state in full hydration. We trapped a-
helical hIAPP in dry lipid bilayers. However, by the time
the samples were hydrated and measured (taking ~5 min),
the peptide had already converted to b-configurations and
exited from the headgroup region.(C) PtP of DOPC/hIAPP changes with P/L at 92% RH.DISCUSSION
The new (to our knowledge) structural information obtained
from our experiments is that the b-aggregates of hIAPP bind
on the surface of lipid bilayers; they do not penetrate into the
bilayer structure. This is true even when the b-aggregates
originated from a-helical hIAPPs bound inside the head-
group region of the lipid bilayer. This behavior of hIAPP is
identical to the previous finding with the amyloidogenic
peptide penetratin (34). Thus, it could be a common pattern
of interaction between amyloid-forming peptides and lipid
bilayers, i.e., the peptides bind as helices inside the head-
group region of the bilayer, but once the peptides convert to
b-aggregates, they bind on the aqueous surface of the bilayer.The GUVexperiments with monomeric hIAPP imply that
there is a threshold bound-peptide/lipid ratio, below which
the bound peptide does not convert to b-aggregates. This
behavior of hIAPP is also similar to penetratin. Such
a threshold is important because the binding of hIAPP
does not damage the lipid bilayer until the peptide converts
into b-aggregates.Interaction of hIAPP b-fibrils with lipid bilayers
Binding of hIAPP b-fibrils to lipid vesicles was observed in
two ways. When an aspirated GUV was exposed to hIAPPBiophysical Journal 102(5) 1059–1068
1066 Lee et al.b-fibrils, the peptide binding did not cause a membrane
expansion—no protrusion length increase, consistent with
surface binding. Instead, the GUV protrusion length quickly
decreased and the GUV ruptured (Fig. 2 B). On the other
hand, if lipid vesicles were dispersed into a b-fibrils suspen-
sion, vesicles and lipids were seen attached to the fibrils and
became part of the fibril aggregates. We stress that hIAPP
b-fibrils bind to both neutral (DOPC) and anionic lipids
(7:3 DOPC/DOPG) and that the same binding phenomena
were observed during the growth of b-fibrils as well as
with preformed b-fibrils. This is contrary to the observation
by Engel et al. (33) who reported interactions only during
the growth of fibrils.
Eisenberg and colleagues (17,18) have resolved the crys-
talline structures of b-amyloid formed by a small peptide
GNNQQNY. The universal cross-b structure for b-amyloids
has three levels of organization: The first is the alignment of
the peptide molecules to form a b-sheet; the second is the
self-complementation of two sheets, forming the pair-of-
sheets structure with a dry interface; in the third level,
pair-of-sheets interact to form a fibril. For an extended
peptide like hIAPP, the organization at each level is bound
to be imperfect (unlike the small peptide GNNQQNY),
namely, there will be unpaired (positive) charges and uncov-
ered hydrophobic regions exposed on the surface of the
fibrils. It is well known that multivalent cations adsorb to
the lipid bilayers of both zwitterionic and acidic headgroups
(51). Therefore, it is not surprising that the positive charges
on the surface of hIAPP b-fibrils bind to the surface of lipid
bilayers. It is also not surprising that lipid molecules bind to
the hydrophobic regions of the fibril surface.
Given such deleterious effects on lipid bilayers, why were
there no interactions between hIAPP b-fibrils and cell
membranes in culture (3,8)? We speculate that perhaps the
b-fibrils formed in solution cannot penetrate the carbohy-
drate layer (glycocalyx) (52) that covers the cell surface, so
the fibrils do not come into contact with plasma membranes.Interaction of hIAPP monomers with lipid bilayers
The hIAPP monomers in solution bind to both the neutral
(zwitterionic) and the anionic lipid bilayers. As expected,
the binding affinity to the latter is stronger. In our experi-
ments, pure lipid GUVs were introduced into a peptide solu-
tion at t ¼ 0. Thus, the bound peptide/lipid ratio P/L
increased with time. In all concentrations, the initial binding
expanded the membrane area without causing molecular
leakage. At the peptide concentration ( 0.05 mM, the
GUV remained in this condition within our experimental
time. No aggregates were observed on the GUV surface
and no damage to lipid bilayers occurred. This clearly
implies that before P/L reaches a threshold value, the bound
peptides do not transform to b-aggregates. However, the
exact value of the threshold P/L is too small (<1/100) to
be measured by the multilayer experiments. In contrast,Biophysical Journal 102(5) 1059–1068the threshold P/L for penetratin has been measured accu-
rately by the multilayer experiments: four different thresh-
olds, between 1/65 and 1/20, in four different lipids (34).
When an aspirated GUV was exposed to monomeric
hIAPP at concentrations T0.5 mM, the initial membrane
expansion reached a limit and then the expansion was
reversed. During the decrease of protrusion length, we
observed small aggregates, which included lipid dye that ap-
peared on the membrane surface, but there was no molecular
leakage (the vesicle phase contrast remained constant).
Eventually the GUV ruptured.
Thus, we can summarize the physical process of interac-
tion between monomeric hIAPP with lipid bilayers as
follows. The hIAPP spontaneously binds to lipid bilayers.
If the bound P/L is below a certain threshold value, the
binding causes a membrane expansion but otherwise causes
no leakage or damage. However, if the P/L exceeds the
threshold value, the bound peptides convert to b-aggregates,
which exit from the bilayer and bind on the bilayer surface.
The process of conversion to the b-aggregates probably
extracts lipid molecules from the bilayer. As long as the
b-aggregates are sufficiently small, the extraction of lipid
does not cause molecular leakage. However, small b-aggre-
gates seed the formation of fibrils, as demonstrated by the
Jarrett-Lansbury model (53). The large size fibrils eventu-
ally rupture the lipid bilayer via electrostatic and hydro-
phobic interactions.
Our observation at high concentrations of monomeric
hIAPP essentially agrees with Engel et al. (33). Many
previous investigations have reported ion conduction caused
by hIAPP monomers while detecting no molecular leakage
(3,4,15,27–29). This phenomenon may be correlated to the
extraction of lipid molecules from the bilayer during the
hIAPPs conversion to b-aggregates. It has been reported
that defects of a lipid bilayer allow ion conduction, for
example near the fluid-gel phase transition point, but no
molecular leakage (54).
Finally, as stated previously, we speculate that b-fibrils
cannot pass through the glycocalyx to reach the plasma
membranes of cells, but we assume that hIAPP monomers
can pass through the glycocalyx. The latter assumption is
based on the observation that antimicrobial peptides (which
are monomeric in solution and many of them are of similar
size of hIAPP) can readily reach the plasma membranes
(55). Based on our knowledge of how hIAPP interacts
with lipid bilayers, the soluble monomers is the most likely
form of hIAPP that could affect cell membranes in culture.
The possible damage strongly depends on the peptide
concentration. The damage caused by high concentrations
of hIAPP may not occur in low concentrations.SUPPORTING MATERIAL
Thioflavin T dye binding assay for fibril formation, hIAPP-induced GUV
protrusion decrease was not by pore formation, two figures, and a movie
How hIAPP Damages Lipid Bilayers 1067are available at http://www.biophysj.org/biophysj/supplemental/S0006-
3495(12)00154-3.
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